Investigator Awards - Neuroendocrine Tumor Research Foundation
Forecasted
Investigator Awards - Neuroendocrine Tumor Research Foundation support researchers pursuing basic, translational, and select clinical studies to advance neuroendocrine cancer detection and treatment.
Browse similar grants
Funder: Neuroendocrine Tumor Research Foundation
Due Dates (Anticipated): March 2027 (LOI) | June 2027 (Full application)
Funding Amounts: Up to $300,000 over two years ($150,000 per year), including indirect costs
Summary: Supports innovative basic, translational, and select clinical research to advance understanding and treatment of neuroendocrine cancers.
Key Information: Applicants must hold an MD, PhD, MD/PhD, or equivalent and an Assistant Professor-level or higher faculty appointment.
Description
The Neuroendocrine Tumor Research Foundation (NETRF) Investigator Awards support transformative research addressing critical questions in neuroendocrine cancer biology and removing barriers to therapeutic development. Projects must advance at least one pillar of NETRF’s Research Roadmap: early detection, new therapeutic development, or precision medicine. The foundation primarily supports basic and translational research, with select clinical research considered when especially compelling and positioned to accelerate progress for patients.
Awards support a defined two-year project, typically organized around two aims or three smaller aims, comparable in scope to an NIH R21 grant. Projects usually have a single principal investigator, with or without collaborators. NETRF welcomes international applications and strongly encourages collaboration across scientific disciplines.
